Literature DB >> 21507581

Targeting death receptor induced apoptosis and necroptosis: a novel therapeutic strategy to prevent neuronal damage in retinal detachment.

K Dong1, X Sun.   

Abstract

Retinal detachment (RD) is a common cause of human visual impairment. Detachment of photoreceptors from the retinal pigment epithelium causes photoreceptor loss and subsequent vision decline. Death receptor (DR)-induced apoptosis play critical role in activating apoptosis in photoreceptor cells. Z-VAD-FMK inhibits the DR-induced retinal neuronal apoptosis but promotes neuronal death through necroptosis pathway, an alternative programmed cell death, which can be inhibited by Nec-1. Thus, we may achieve a better result by simultaneous inhibition of DR-induced apoptosis and necroptosis, which provides us with a new direction in the treatment of RD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507581     DOI: 10.1016/j.mehy.2011.03.049

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Activation of autophagy in photoreceptor necroptosis after experimental retinal detachment.

Authors:  Kai Dong; Zi-Cheng Zhu; Feng-Hua Wang; Gen-Jie Ke; Zhang Yu; Xun Xu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

2.  Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration.

Authors:  Kevin Puertas-Neyra; Nadia Galindo-Cabello; Leticia A Hernández-Rodríguez; Fernando González-Pérez; José Carlos Rodríguez-Cabello; Rogelio González-Sarmiento; José Carlos Pastor; Ricardo Usategui-Martín; Ivan Fernandez-Bueno
Journal:  Front Neuroanat       Date:  2022-02-11       Impact factor: 3.856

3.  Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death.

Authors:  Ricardo Usategui-Martín; Kevin Puertas-Neyra; Nadia Galindo-Cabello; Leticia A Hernández-Rodríguez; Fernando González-Pérez; José Carlos Rodríguez-Cabello; Rogelio González-Sarmiento; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.